Excipient Market Overview: Clariant sets up its first PEG excipients facility in US; India harmonizes 22 excipient monographs

DATA COMPILATION
#PharmaFlow

Pipeline Prospector March 2026 highlights: Lilly to acquire Centessa for US$ 7.8 bn; Merck buys Terns Pharma for US$ 6.7 bn

Stock Recap
#PipelineProspector

2-FTC

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

40 API Suppliers, 17 USDMF, 2 JDMF, 12 EU WC, 6 KDMF, 17 NDC API, 16 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

71 Drugs in Development

71 Drugs in Development

INTERMEDIATES

1 Intermediate Suppliers

1 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

329 FDF Dossiers, 58 FDA Orange Book, 163 Europe, 22 Canada, 20 Australia, 53 South Africa, 13 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - 200MG;EQ 25MG BASE;300MG, TABLET;ORAL - 150MG;150MG;200MG;300MG, TABLET;ORAL - 150MG;150MG;200MG;EQ 10MG BASE, TABLET;ORAL - 120MG;EQ 15MG BASE, TABLET;ORAL - 200MG;EQ 25MG BASE, TABLET;ORAL - 200MG;EQ 25MG BASE;EQ 25MG BASE, TABLET;ORAL - EQ 30MG BASE;120MG;EQ 15MG BASE, TABLET;ORAL - EQ 50MG BASE;200MG;EQ 25MG BASE, CAPSULE;ORAL - 200MG, TABLET;ORAL - 100MG;150MG, TABLET;ORAL - 133MG;200MG, TABLET;ORAL - 167MG;250MG, TABLET;ORAL - 200MG;300MG

RELATED EXCIPIENT COMPANIES

1 Rochem International Inc, 4 SPI Pharma, 1 Boai NKY Pharmaceuticals Ltd, 4 Gangwal Healthcare, 4 Nanjing Well Pharmaceutical, 2 Kirsch Pharma, 1 Dr. Paul Lohmann GmbH & Co. KGaA, 4 ACG Worldwide, 5 Actylis, 1 Aeon Procare, 7 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 1 Ashland, 26 BASF, 10 Corel Pharma Chem, 5 DFE Pharma, 1 Esteem Industries, 2 Finar, 8 Gangwal Chemicals, 1 Gloria Interchem, 5 Ideal Cures, 3 Ingredion Pharma Solutions, 21 Kerry, 2 Keval Exports, 3 Kima Chemical, 6 Lonza Capsugel, 11 Microlex e.U, 1 Neelkanth MineChem, 2 Nitika Pharmaceutical Specialities, 2 Nomisma Healthcare, 3 Novo Excipients, 2 Pharmatrans-Sanaq, 6 Pluviaendo, 3 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 2 Qualicaps, 16 Roquette, 9 Seppic, 5 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 10 Sigachi Industries, 3 Silverline Chemicals, 2 The Dow Chemical Company, 1 Valens Pharmachem, 3 Vasa Pharmachem, 1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

50 Fillers, Diluents & Binders, 46 Coating Systems & Additives, 27 Controlled & Modified Release, 25 Granulation, 22 Direct Compression, 20 Thickeners and Stabilizers, 18 Disintegrants & Superdisintegrants, 17 Solubilizers, 17 Topical, 15 Lubricants & Glidants, 11 Parenteral, 11 Film Formers & Plasticizers, 11 Co-Processed Excipients, 11 Taste Masking, 9 Empty Capsules, 8 Chewable & Orodispersible Aids, 6 Emulsifying Agents, 5 API Stability Enhancers, 4 Vegetarian Capsules, 4 Surfactant & Foaming Agents, 3 Rheology Modifiers, 2 Coloring Agents

DIGITAL CONTENT

4 Data Compilation #PharmaFlow, 2 Stock Recap #PipelineProspector, 200 News #PharmaBuzz

GLOBAL SALES INFORMATION

24 US Medicaid Prescriptions, 6 Regulatory FDF Prices, 120 Annual Reports

MARKET PLACE

9 APIs, 9 FDF Dossiers

PATENTS & EXCLUSIVITIES

80 US Patents, 10 US Exclusivities, 54 Health Canada Patents

REF. STANDARDS & IMPURITIES

4 USP, 6 Others

$ Xls download

Filters

Last Updated on PharmaCompass	Virtual Booth	Country	Holder	DMF No.	Subject	Submission Date	Status	Type	GDUFA DMF Review	GDUFA Review Date	GDUFA Payment Date
31/03/2026	Honour Lab Limited	India	HONOUR LAB LTD	28505	EMTRICITABINE	2014-08-04	Inactive	II	N/A
31/03/2026	Arene Lifesciences	India	ARENE LIFE SCIENCES PRIVATE LTD	34105	EMTRICITABINE	2019-10-17	Active	II	N/A

Privacy policy
Terms and conditions
Disclaimers
Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

2-FTC

2-FTC

ACCESS ALL DATA

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

40 API Suppliers

17 USDMF

2 JDMF

12 EU WC

6 KDMF

17 NDC API

16 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

71 Drugs in Development

INTERMEDIATES

1 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

329 FDF Dossiers

58 FDA Orange Book

163 Europe

22 Canada

20 Australia

53 South Africa

13 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - 200MG;EQ 25MG BASE;300MG

TABLET;ORAL - 150MG;150MG;200MG;300MG

TABLET;ORAL - 150MG;150MG;200MG;EQ 10MG BASE

TABLET;ORAL - 120MG;EQ 15MG BASE

TABLET;ORAL - 200MG;EQ 25MG BASE

TABLET;ORAL - 200MG;EQ 25MG BASE;EQ 25MG BASE

TABLET;ORAL - EQ 30MG BASE;120MG;EQ 15MG BASE

TABLET;ORAL - EQ 50MG BASE;200MG;EQ 25MG BASE

CAPSULE;ORAL - 200MG

TABLET;ORAL - 100MG;150MG

TABLET;ORAL - 133MG;200MG

TABLET;ORAL - 167MG;250MG

TABLET;ORAL - 200MG;300MG

RELATED EXCIPIENT COMPANIES

1 Rochem International Inc

4 SPI Pharma

1 Boai NKY Pharmaceuticals Ltd

4 Gangwal Healthcare

4 Nanjing Well Pharmaceutical

2 Kirsch Pharma

1 Dr. Paul Lohmann GmbH & Co. KGaA

4 ACG Worldwide

5 Actylis

1 Aeon Procare

7 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

1 Ashland

26 BASF

10 Corel Pharma Chem

5 DFE Pharma

1 Esteem Industries

2 Finar

8 Gangwal Chemicals

1 Gloria Interchem

5 Ideal Cures

3 Ingredion Pharma Solutions

21 Kerry

2 Keval Exports

3 Kima Chemical

6 Lonza Capsugel

11 Microlex e.U

1 Neelkanth MineChem

2 Nitika Pharmaceutical Specialities

2 Nomisma Healthcare

3 Novo Excipients

2 Pharmatrans-Sanaq

6 Pluviaendo

3 Prachin Chemical

1 Qianhao Chemical (Hebei) Co., Ltd

2 Qualicaps

16 Roquette

9 Seppic

5 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

10 Sigachi Industries